276 related articles for article (PubMed ID: 19433657)
1. Association of glucocerebrosidase mutations with dementia with lewy bodies.
Clark LN; Kartsaklis LA; Wolf Gilbert R; Dorado B; Ross BM; Kisselev S; Verbitsky M; Mejia-Santana H; Cote LJ; Andrews H; Vonsattel JP; Fahn S; Mayeux R; Honig LS; Marder K
Arch Neurol; 2009 May; 66(5):578-83. PubMed ID: 19433657
[TBL] [Abstract][Full Text] [Related]
2. Lewy body-related alpha-synucleinopathy in aging.
Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
[TBL] [Abstract][Full Text] [Related]
3. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
[TBL] [Abstract][Full Text] [Related]
4. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease.
Clark LN; Chan R; Cheng R; Liu X; Park N; Parmalee N; Kisselev S; Cortes E; Torres PA; Pastores GM; Vonsattel JP; Alcalay R; Marder K; Honig LL; Fahn S; Mayeux R; Shelanski M; Di Paolo G; Lee JH
PLoS One; 2015; 10(5):e0125204. PubMed ID: 25933391
[TBL] [Abstract][Full Text] [Related]
5. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features of Alzheimer Disease With and Without Lewy Bodies.
Chung EJ; Babulal GM; Monsell SE; Cairns NJ; Roe CM; Morris JC
JAMA Neurol; 2015 Jul; 72(7):789-96. PubMed ID: 25985321
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
9. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Trojanowski JQ; Schellenberg GD; Yearout D; Huston H; Fritts-Penniman A; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP
Neurology; 2012 Nov; 79(19):1944-50. PubMed ID: 23035075
[TBL] [Abstract][Full Text] [Related]
10. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
11. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies.
Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K
Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900
[TBL] [Abstract][Full Text] [Related]
12. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Mata IF; Samii A; Schneer SH; Roberts JW; Griffith A; Leis BC; Schellenberg GD; Sidransky E; Bird TD; Leverenz JB; Tsuang D; Zabetian CP
Arch Neurol; 2008 Mar; 65(3):379-82. PubMed ID: 18332251
[TBL] [Abstract][Full Text] [Related]
13. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
Goker-Alpan O; Lopez G; Vithayathil J; Davis J; Hallett M; Sidransky E
Arch Neurol; 2008 Oct; 65(10):1353-7. PubMed ID: 18852351
[TBL] [Abstract][Full Text] [Related]
15. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
[TBL] [Abstract][Full Text] [Related]
16. Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease.
Parkkinen L; Neumann J; O'Sullivan SS; Holton JL; Revesz T; Hardy J; Lees AJ
Mol Genet Metab; 2011 Aug; 103(4):410-2. PubMed ID: 21621439
[TBL] [Abstract][Full Text] [Related]
17. High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.
Shiner T; Mirelman A; Gana Weisz M; Bar-Shira A; Ash E; Cialic R; Nevler N; Gurevich T; Bregman N; Orr-Urtreger A; Giladi N
JAMA Neurol; 2016 Dec; 73(12):1448-1453. PubMed ID: 27723861
[TBL] [Abstract][Full Text] [Related]
18. Glucocerebrosidase mutations in diffuse Lewy body disease.
Nishioka K; Ross OA; Vilariño-Güell C; Cobb SA; Kachergus JM; Mann DM; Snowden J; Richardson AM; Neary D; Robinson CA; Rajput A; Papapetropoulos S; Mash DC; Pahwa R; Lyons KE; Wszolek ZK; Dickson DW; Farrer MJ
Parkinsonism Relat Disord; 2011 Jan; 17(1):55-7. PubMed ID: 20971030
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of cognitively normal elderly.
Knopman DS; Parisi JE; Salviati A; Floriach-Robert M; Boeve BF; Ivnik RJ; Smith GE; Dickson DW; Johnson KA; Petersen LE; McDonald WC; Braak H; Petersen RC
J Neuropathol Exp Neurol; 2003 Nov; 62(11):1087-95. PubMed ID: 14656067
[TBL] [Abstract][Full Text] [Related]
20. APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.
Garcia-Segura ME; Fischer CE; Schweizer TA; Munoz DG
J Alzheimers Dis; 2019; 72(4):1077-1087. PubMed ID: 31744003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
